Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization

N Engl J Med. 2023 Sep 28;389(13):1159-1161. doi: 10.1056/NEJMp2310330. Epub 2023 Sep 9.

¹ From the Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban (S.S.A.K.); the Department of Epidemiology, Mailman School of Public Health, Columbia University (S.S.A.K.), and Weill Cornell Medicine (H.E.V., J.W.P.) - both in New York; Paris (F.B.-S.); Makerere University School of Public Health, Kampala, and Rakai Health Sciences Program, Kalisizo - both in Uganda (D.S.); the Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi (E.B.); the Departments of Global Health and Obstetrics and Gynecology, University of Washington, Seattle (E.B.); the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, and the School of Medicine and Pharmacy, Université Cheikh Anta Diop - both in Dakar, Senegal (S.M.); Monash University Malaysia, Selangor, and the Faculty of Medicine, University of Malaya, Kuala Lumpur - both in Malaysia (A.K.); the M.S. Swaminathan Research Foundation, Chennai, India (S.S.); and Les Centres GHESKIO, Port-au-Prince, Haiti (J.W.P.).

No abstract available

MeSH terms